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Abstract – Salmonella enterica serovar Choleraesuis (Salmonella Choleraesuis) causes a lethal systemic
infection (salmonellosis) in swine. Live attenuated Salmonella Choleraesuis vaccines are effective in
preventing the disease, and isolates of Salmonella Choleraesuis with mutations in the cAMP-receptor
protein (CRP) gene (Salmonella Choleraesuis Dcrp) are the most widely used, although the basis of the
attenuation remains unclear. The objective of this study was to determine if the attenuated phenotype of
Salmonella Choleraesuis Dcrp was due to alterations in susceptibility to gastrointestinal factors such as
pH and bile salts, ability to colonize or invade the intestine, or cytotoxicity for macrophages. Compared
with the parental strain, the survival rate of Salmonella Choleraesuis Dcrp at low pH or in the presence of
bile salts was higher, while the ability of the mutant to invade intestinal epithelia was signiﬁcantly
decreased. In examining the role of CRP on the secretory function of the Salmonella pathogenicity island
1 (SPI-1) encoded type III secretion system (T3SS), it was shown that Salmonella Choleraesuis Dcrp was
unable to secrete the SPI-1 T3SS effector proteins, SopB and SipB, which play a role in Salmonella
intestinal invasiveness and macrophage cytotoxicity, respectively. In addition, caspase-1 dependent
cytotoxicity for macrophages was signiﬁcantly reduced in Salmonella Choleraesuis Dcrp. Collectively,
this study demonstrates that the CRP affects the secretory function of SPI-1 T3SS and the resulting ability
to invade the host intestinal epithelium, which is a critical element in the pathogenesis of Salmonella
Choleraesuis.
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Salmonella enterica serovar Choleraesuis
(herein termed Salmonella Choleraesuis) is
one of the prevalent serovars causing
salmonellosis in swine. Clinically, pigs infected
by Salmonella Choleraesuis develop not only
gastroenteritis, but also lethal systemic manifes-
tations including pneumonia, hepatitis, and
meningitis [32]. Although Salmonella Chole-
raesuis is a host-adapted pathogen of pigs, stud-
ies have revealed this serovar may also cause
systemic infections in humans [6, 7]; however,
the relationship between isolates of Salmonella
Choleraesuis from humans and swine remains
to be elucidated [4].
Vaccinesrepresentaneffectivestrategyforthe
control of swine salmonellosis [32]. However,
bacterins composed of inactivated cultures of
Salmonella are less effective than live vaccines
consisting of attenuated strains of Salmonella
[15]. During the past decades, a variety of live
attenuated Salmonella Choleraesuis mutants
have been developed as vaccine candidates.
These include strains having mutations in genes
involved in purine synthesis (pur), thymidine
synthesis (thy), the cAMP-receptor protein (crp),
adenylate cyclase (cya), type III secretion system
(T3SS) apparatus (ssaC, ssaJ and ssaV), Gifsy-1
prophage protein (gifsy-1), and D-galactonate
transport protein (dgoT)[ 8, 19–21, 27]. Among
these, Salmonella Choleraesuis strains with
mutations in crp alone or in combination with
other genes were shown to be greatly attenuated
in virulence and to serve as effective vaccine
candidatesagainstswinesalmonellosis[8,20,34].
In Escherichia coli, the cAMP-receptor pro-
tein (CRP) activates transcription of more than
100 genes and acts as a global gene regulator
[22]. Upon coupling with the allosteric effector,
cyclic AMP, dimeric CRP initiates transcription
by binding to speciﬁc DNA sites and enhancing
the binding of RNA polymerase holoenzyme to
activate transcription [2]. In this manner, regu-
lons or genes involved in the uptake and utiliza-
tion of carbon source, ﬂagellum synthesis, iron
uptake, glycogen synthesis, outer membrane
proteins etc. are regulated in E. coli and Salmo-
nella Typhimurium [1, 22]. Moreover, inser-
tional mutations in crp and cya have been
reported to affect the production of proteins
exported by the Ysc (Yersinia secretion), Ysa
(Yersinia secretion apparatus), and ﬂagellar
T3SS in Yersinia enterocolitica [29]. Neverthe-
less, little was known regarding the role of CRP
in Salmonella virulence until a recent study
reported that crp/cya are required for expression
of sirA gene which is an upstream regulator for
Salmonella pathogenicity island 1 (SPI-1) gene
clusters [37].
The SPI-1 T3SS is one of the virulence
determinants of Salmonella that is important
for intestinal colonization and invasion of epi-
thelial cells as a prelude to systemic infection.
By delivering more than 10 different effector
proteins into the host cells via SPI-1 T3SS, Sal-
monella actively invades intestinal mucosa and
causes enteropathy in the host [31, 42]. More-
over, the SPI-1 T3SS effector protein SipB
induces caspase-1 dependent apoptosis in mac-
rophages and plays an essential role in Salmo-
nella pathogenesis [16, 25, 26]. Therefore, the
aim of this study was to investigate the func-
tional relationship between CRP and SPI-1
T3SS in Salmonella Choleraesuis using a crp
mutant (Dcrp) and to better understand the basis
of attenuation in the mutant strain.
2. MATERIALS AND METHODS
2.1. Bacterial strains, plasmids and media
A wild type (WT) strain of Salmonella enterica
serovar Choleraesuis (No. 13312) and an E. coli
K-12 strain (No. 10798) were obtained from the
American Type Culture Collection (ATCC, Manas-
sas, VA, USA). Bacteria were cultured at 37  Ci n
Luria-Bertani (LB) broth. To induce the expression
of SPI-1 T3SS genes in the experiments described,
bacteria were cultured at 37  Ci nL Bs u p p l e m e n t e d
with 0.3 M NaCl under conditions of low aeration
[14, 28, 36]. Where appropriate, ampicillin
(100 lg/mL), kanamycin (50 lg / m L )o rc h l o r a m -
phenicol (12.5 lg/mL) were added to the medium.
Quantiﬁcation of viable bacteria, expressed as colony
forming units (CFU) per mL of culture or g of tissue,
was determined for each experiment by preparation
of serial dilutions of cultures or tissue homogenates
in phosphate buffered saline (PBS) and plating on
MacConkey or brilliant green (BG) agar plates
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2.2. Construction of crp gene mutants
Mutants were generated by allelic exchange
between suicide vectors and bacterial genomic
DNA using a method described previously [40].
The mutant strains generated in this study are listed
in Table I. Brieﬂy, genomic DNA of Salmonella
Choleraesuis was PCR ampliﬁed using the following
primer pair: 50- cat taa aat ctg gta ccg gag gag gac tct
c- 3 0 and 50- gat gaa ttc cca cca gca gaa gtt gcg tta cca
-30. The resulting 1 318 bp PCR product containing
the full length crp (633 bp) ﬂanked by partial
sequences of the putative inner membrane protein
genes, yhfA and yhfK, was digested with KpnIa n d
EcoRI, ligated into pGP704, and maintained in the
permissive E. coli strain SY327kpir [24]. The result-
ing plasmid was termed pGCRP. Thereafter, a HincII
DNA fragment harboring a kanamycin-resistance
determinant (km) was subsequently cloned and
inserted into the crp gene of pGCRP. The resulting
plasmid, pGCRPK, was a suicide vector for allelic
exchange of crp by transformation into Salmonella
Choleraesuis via electroporation (1.25 kV/cm,
600 X and 25 lF). The resulting bacterium CP327
strain exhibiting kanamycin-resistance and ampicil-
lin-sensitivity was isolated and characterized by
Southern hybridization using DNA probes speciﬁc
to crp and km.
In order to construct a crp mutant free of the km
resistance gene, similar cloning procedures were
applied. Brieﬂy, a km determinant ﬂanked by two
direct repeats of the loxP sequence (50- ata act tcg
tat aat gta tgc tat acg aag tta t -30) was cloned into
the crp gene of pGCRP. The resulting suicide vector
was transformed and resulting mutants with kanamy-
cin-resistance and ampicillin-sensitivity were selected
and genotypically characterized. The selected strain
was a crp mutant harboring a loxP-ﬂanked-kanamy-
cin determinant. To excise the km gene, bacteria were
further transformed with a temperature sensitive
p705-Cre plasmid that harbored a Cre recombinase
gene (Gene Bridges GmbH, Dresden, Germany).
Excision of the km determinant from genomic
DNA of candidate strains via Cre-loxP recombination
was achieved by shifting the incubation temperature
from 30  Ct o4 2 C[ 44]. The increased temperature
induced expression of Cre recombinase and simulta-
neously inhibited replication of p705-Cre, leading to
the elimination of the plasmid. The resulting bacte-
rium CP359 strain lacking an antibiotic gene was fur-
ther identiﬁed by Southern hybridization analysis
(data not shown).
2.3. Construction of plasmids encoding SopB,
SipB and CRP
To construct a plasmid that encoded the N-termi-
nal Myc-tagged SopB, genomic DNA of Salmonella
Choleraesuis was ampliﬁed by PCR using primer pair
sopB P1(F) and sopB P2(R) as shown in Table II.
The resulting sopB gene was restriction digested with
BglII and HindIII, and ligated into a pUC19 vector
(GenBank Accession L09137) that harbored a pro-
moter region for the neomycin determinant of the
Tn5 transposon (GenBank Accession U00004). The
resulting pTSopB plasmid contains the sopB-myc
gene that is transcriptionally regulated by the neomy-
cin promoter in cis. Similar procedures were used in
the construction of plasmids pTSipB and pTCRP
expressing N-terminal Myc-tagged SipB and CRP,
respectively, using the pUC19 vector as a backbone
(Tab. II).
Additionally, a plasmid that harbored the pSC101
replication of origin and the crp gene was con-
structed. Brieﬂy, a p705 M plasmid that served as
the backbone was generated from modiﬁcation of
p705-Cre by BamHI digestion and self-ligation. To
Table I. Bacterial strains used in this study.
Strain Genotype Relevant characteristics Source
Salmonella enterica serovar Choleraesuis
WT Wild type ATCC, No. 13312
CP327 crp-327::km Derived from WT, Km
R This study
CP359 crp-359::loxP Derived from WT This study
PQ518 phoQ518::km Derived from WT, Km
R This study
Escherichia coli
K12 Wild type ATCC, No. 10798
Salmonella Choleraesuis Dcrp affects SPI-1 T3SS Vet. Res. (2010) 41:05
(page number not for citation purpose) Page 3 of 14clone crp into p705 M, the crp gene was PCR ampli-
ﬁed using primers crp P3(F) and crp P3(R) with
pTCRP as the template. The PCR product was
restriction digested with BamHI and ligated into
p705 M. The plasmid was termed p705CRP.
2.4. Complementation experiments
Complementation experiments were performed
by transformation of pTCRP or p705CRP plasmids
into CP327 strain via electroporation (1.25 kV/cm,
600 X and 25 lF). In the experiments of in vitro
survival and LDH assay, the pTCRP plasmid was
used. The secretory function of the complemented
Salmonella Choleraesuis Dcrp was investigated by
co-transformation of pTSopB and p705CRP into
CP327. These two plasmids are compatible in the
CP327 strain.
2.5. In vitro survival assay
Stationary phase cultures of Salmonella in LB
were washed twice with PBS, and resuspended in
control media. The control medium was M9 (pH
7.0) for the acid killing assay and saline (0.9% NaCl,
pH 7.0) for the bile salts killing assay. Approximately
1 · 10
8 CFU of bacteria were inoculated into the M9
medium (pH 3.0), 15% bile salts in saline (Becton,
Dickinson and Company), 1% sodium deoxycholate
in saline (Becton, Dickinson and Company), or
control medium, followed by gentle mixing and
incubation at 37  C for 1 h. After incubation, viable
bacterial counts were determined on MacConkey
agar plates. The percentage of surviving bacteria
was calculated as the number of viable bacteria
before incubation/the number of viable bacteria after
incubation.
2.6. Secretion assay and Western blot analysis
Salmonella strains harboring appropriate plas-
mid(s) were cultured into LB broth containing
0.3 M NaCl and grown at 37  C overnight. The bac-
terial pellets were collected by centrifugation at
30 0 0· g for 10 min, resuspended in the same med-
ium to   1 · 10
9 CFU/mL and incubated at 37  C
for an additional 3 h. Thereafter, bacterial pellets
were collected by centrifugation and culture superna-
tants were passed through a ﬁlter with a pore-size of
0.45 lm (Millipore, Billerica, MA, USA). All sam-
ples were normalized to the OD595 nm values deter-
m i n e da th a r v e s ta n ds u b j e c t e dt oW e s t e r nb l o t
analysis. The protein bands on immunoblots recog-
n i z e db ya n t i - M y ca n t i b o d y( A b c a m ,C a m b r i d g e ,
UK) represented the quantity of recombinant proteins
present within bacterial cells or that were secreted by
bacteria into culture supernatants. Signals from
immunoblots probed with an anti-DnaK antibody
(Merck, Darmstadt, Germany) represented the quan-
tity of bacteria in pelleted fractions or in the superna-
tants containing lysed cells. The intensity of the
bands was quantiﬁed by analysis of the scanned
Table II. Oligonucleotide primers used and plasmids constructed in this study.
Primer Sequences (50 ! 30)
a Plasmid
sopB P1(F) CAGAGATCTGATCAAGAGACAGGATGAGGATCGTTTCGC
ATGCAAATACAGAGCTTC
pTSopB
sopB P2(R) CCGAAGCTTTTACAGATCCTCTTCAGAGATGAGTTTCTGCTCAG
ATGTGATTAATGAAGA
sipB P1(F) CAGAGATCTGATCAAGAGACAGGATGAGGATCGTTTCGCAT
GGTAAATGACGCAAGTAGCATTAG
pTSipB
sipB P2(R) CCGCTGCAGTTACAGATCCTCTTCAGAGATGAGTTTCTGCTCTGCG
CGACTCTGGCGCAGAATAAAACG
crp P1(F) CAGAGATCTGATCAAGAGACAGGATGAGGATCGTTTCGCATG
GTGCTTGGCAAACC
pTCRP
crp P2(R) CCGAAGCTTTTACAGATCCTCTTCAGAGATGAGTTTCTGCTCACGGGTGC
CGTAGACGA
crp P3(F) AATGCCGGATCCTGGACAGCAAGCGAACCGGAATTGCC p705CRP
crp P3(R) CGGGGATCCTCACACAGGAAACAGCTATGAC
a The Myc-tag sequences are shown in italics. Restriction sites are underlined. Stop codons are shown in bold
italics. Sequences of partial neomycin promoter of Tn5 transposon are shown in bold.
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2.7. Animal experiments
The animals used in this study were cared for and
handled according to the guidelines approved by the
Institutional Animal Care and Use Committee
(IACUC) of the National Chung Hsing University
(permit number 94-67).
2.7.1. LD50 in mice
Healthy female BALB/c mice at 6 to 8 weeks of
age were purchased from the National Laboratory
Animal Center, Taiwan. The virulence of the Salmo-
nella Choleraesuis strains was determined using both
peroral(p.o.)andintraperitoneal(i.p.)routesofadmin-
istration. For p.o. inoculations, mice were deprived of
food and water for 4 h and orally given 30 lLo f1 0 %
sodium bicarbonate (Sigma, St. Louis, MO, USA)
5 min before administration of 40 lL of serially
diluted Salmonella Choleraesuis in PBS. Food and
water were resupplied 30 min after p.o. inoculation
of bacteria. Intraperitoneal inoculation of mice was
performed by injecting 100 lL of a bacterial suspen-
sionintotheabdomen[9].Micethatappearedseverely
ill were euthanized. Mortality was recorded at 21 days
post inoculation and the LD50 was calculated by the
method of Reed and Muench [30].
2.7.2. Porcine ligated ileal loop
Male Landrace · Yorkshire (LY) pigs at 8 weeks
o fa g ew e r eo b t a i n e df r o mal o c a lc o m m e r c i a ls u p -
plier. Pigs were conﬁrmed to be negative for Salmo-
nella prior to experiments by overnight enrichment
of rectal swabs in Rappaport broth (Becton, Dickin-
son and Company) at 37  C, followed by culture on
BG agar plates overnight. For surgical manipulations,
pigs were sedated by intramuscular administration of
4 mg/kg Stresnil (Janssen Animal Health, High
Wycombe, UK), followed by induction of anesthesia
by intravenous administration of 8 mg/kg thiamylal
sodium (Shinlin Sinseng Pharmaceutical, Taiwan,
R.O.C.), and maintenance of anesthesia with 2% iso-
ﬂurane (Halocarbon Laboratories, River Edge, NJ,
USA) in oxygen via an endotracheal tube. When a
deep stage of anesthesia was reached, a midline inci-
sion was made through the abdominal wall, the ileo-
cecal junction was revealed, and sequential 6-cm
loops with 1-cm spacers were constructed with surgi-
cal silk. Twelve ileal loops were constructed in each
pig and randomly assigned for bacterial inoculation.
Bacteria grown under conditions to induce SPI-1
T3SS wereinjectedintoassignedloopsataconcentra-
tion of 1 · 10
9 CFU/5 mL per loop. At least triplicate
loops were injected for each bacterial strain. The
abdomen was then closed with surgical thread and
anesthesia was maintained for 3 h to allow intestinal
invasion of bacteria. Thereafter, animals were eutha-
nized and the ileal loops accompanied with the
associated mesenteric lymph nodes were harvested.
To quantify the invasion of Salmonella,t h ei l e a l
loops were dissected and gently washed with
250 mL of ice-cold saline to remove mucus and
excess bacteria in the lumen. The intestinal walls with
Peyer patches were harvested and were homogenized
in PBS containing 0.5% bovine serum albumin
(Sigma) and 0.5% Tergitol TM10 (Fluka, Buchs,
Switzerland). Serial dilutions of homogenates of the
intestine or mesenteric lymph nodes were plated on
BG agar with appropriate antibiotic and incubated
overnight at 37  C. Bacterial counts in each prepara-
tion were performed as described previously.
2.8. Invasion and intracellular survival assays
Porcine alveolar macrophages (PAM) were
obtained from 3- to 6-week old healthy piglets
through lavage and stored in liquid nitrogen as previ-
ously described [5, 18]. For experiments, PAM were
thawed, resuspended and cultured in RPMI-1640
(Invitrogen, Carlsbad, CA, USA) supplemented with
10% fetal bovine serum (FBS), 2 mM L-glutamine,
100 U/mL penicillin, 100 lg/mL streptomycin, and
2.5 lg/mL amphotericin B. Invasion and survival
assays were performed as described previously with
minor modiﬁcations [10, 12]. Brieﬂy, PAM were pla-
ted in 96-well tissue culture plates at a density of
2 · 10
5 cells per well and incubated at 37  Ci n
5% CO2 overnight. Fifty microliters of SPI-1 T3SS
induced bacteria in culture medium (RPMI-1640 sup-
plemented with 10% FBS) were added to PAM in
each well to provide a ﬁnal multiplicity of infection
(MOI) of   20. The plates were then centrifuged at
167 · g for 5 min and incubated at 37  Ci n5 %
CO2 to allow invasion. Two hours post inoculation
(hpi), the cells were washed ﬁve times with culture
medium and incubated in 200 lL of culture medium
supplemented with 100 lg/mL gentamicin (Gibco
Labs, Grand Island, NY, USA) for an additional
2 h in order to kill extracellular bacteria. Subse-
quently, the medium was replaced with culture med-
ium containing 10 lg/mL gentamicin. At 4, 8 and
16 hpi, the cells were washed once with culture med-
ium and lysed in 200 lLo f0 . 1 %T r i t o nX - 1 0 0i n
PBS for 5 min. Cell lysates were diluted serially in
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number of bacteria surviving intracellularly. The
invasiveness of each strain was calculated as follows:
CFU at 4 hpi/total bacterial counts at 2 hpi, and
the relative invasion rate was expressed after
normalization to WT. The survival rate of each strain
at 8 or 16 hpi was calculated as (CFU at 8 or 16 hpi/
CFU at 4 hpi) · 100%.
2.9. LDH assay
Murine RAW 264.7 macrophage cells were main-
tained in RPMI-1640 supplemented with 10% FBS.
Bacteria grown under conditions that induce SPI-1
T3SSwereused[28].Todeterminethecytotoxiceffect
of Salmonella, RAW 264.7 macrophage cells were
seeded onto 96-well cell culture plates at a density of
5 · 10
4 cells/well and incubated at 37  C overnight.
ThecellswerewashedwithRPMI-1640andincubated
for 1 h in RPMI-1640 containing 50 lMo ft h ec a s -
pase-1 inhibitor Ac-YVAD-CMK (Calbiochem,
Darmstadt, Germany) or the vehicle (0.5% dimethyl-
sulfoxide, DMSO) used to dissolve the caspase-1
inhibitor. Bacterial suspensions representing an MOI
of   50 were added to the cell cultures and incubated
f o r1ha t3 7 C. Thereafter, low serum media with
gentamicin (RPMI-1640 containing 1% FBS,
100 lg/mL gentamicin, and 50 lM Ac-YVAD-
CMK or 0.5% DMSO) was added to kill extracellular
bacteria and the cultures were incubated for an addi-
tional 6 h. Cytotoxicity was quantiﬁed using a kit
(Roche,Basel, Switzerland)thatdetectsLDH released
from the cytoplasm. Percent cytotoxicity was calcu-
lated as 100 · ((experimental release   spontaneous
release)/(total release   spontaneous release)), in
which the spontaneous release was the amount of
LDH activity in the supernatant of uninfected cells
and the total release of LDH was measured from cells
l y s e dw i t h1 %T r i t o nX - 1 0 0( S i g m a ) .
3. RESULTS
3.1. The Salmonella Choleraesuis Dcrp was
attenuated in BALB/c mice
To examine the role of the crp gene in the
virulence of Salmonella Choleraesuis, BALB/c
mice were infected by p.o. or i.p. administration
of the WT strain of Salmonella Choleraesuis or
an isogenic crp gene mutant strain CP327. The
resultsshowedthattheWTstrainwashighlyvir-
ulent with an LD50 of 2.4 · 10
1 CFU and
1.2 · 10
6 CFU via delivery by i.p. and p.o.
routes, respectively. Mice infected with the WT
isolate developed acute systemic symptoms
and death was observed within 10 days post
inoculation (Fig. 1). By contrast, CP327 was
greatly attenuated with LD50 doses of
3.5 · 10
4 CFU (i.p.) and > 2.1 · 10
10 CFU
(p.o.),thatwereapproximately10
3-and10
4-fold
greater than those for the WT, respectively
(Fig. 1). Mice inoculated with CP327 showed
ahightoleranceforinfectionbythemutantstrain
and survived longer compared with those
infected with WT, i.e. 40% of mice survived at
2 weeks after i.p. injection with 1 · 10
5 CFU
of Dcrp. Notably, all mice challenged with
2.1 · 10
10 CFU of CP327 delivered p.o. sur-
vived throughout the experimental period, indi-
cating that CP327 was highly attenuated when
administered via this route.
3.2. Attenuation of Dcrp was not due to greater
susceptibility to low pH or bile salts
The fecal-oral route is the primary pathway
for transmission of Salmonella infections
among swine [11]. Before intestinal coloniza-
tion, Salmonella needs to overcome the bacteri-
cidal effects of gastric acid and bile salts present
in the upper alimentary tract. To determine if
the attenuation of the Dcrp mutant was due to
increased susceptibility to these bactericidal fac-
tors, survival of bacteria under conditions mim-
icking gastric acid and bile were investigated.
The results show that both WT and Dcrp
(CP327 and CP359) were highly sensitive to
low pH (pH 3.0) with nearly 50% of bacteria
being killed after 1 h incubation (Fig. 2A).
However, the Dcrp strains showed   10%
higher resistance than WT (p < 0.05) indicating
that Dcrp strains were less susceptible to acidic
environments. Furthermore, incubation of WT
in the presence of 15% bile salts or 1% sodium
deoxycholate (an active component of bile)
resulted in the inactivation of nearly 30% and
60% of the bacteria, respectively (Fig. 2B).
By contrast, Dcrp strains were signiﬁcantly
m o r er e s i s t a n tt ob o t hr e a g e n t st h a nt h eW T
and the sensitivity of the CP327 was restored
by complementation in trans with a plasmid
encoding CRP (Figs. 2A and 2B).
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During infection, Salmonella Choleraesuis
must penetrate the intestinal epithelial barrier
prior to establishing systemic infection. To
examine the role of the crp gene in intestinal
invasiveness, an in vivo experiment was per-
formed using porcine ligated ileal loops. The
result shows that, 3 h after incubation, fewer
colonies of CP327 were recovered from the
ileal wall and associated Peyer patches as com-
pared to WT (p < 0.05). Further examination of
the Salmonella strains that had penetrated the
intestinal epithelial barrier revealed that signiﬁ-
cantly fewer CP327 were recovered from the
mesenteric lymph nodes as compared to WT
(p < 0.001) (Fig. 3A) suggesting that the muta-
tion in the crp gene was associated with
reduced intestinal colonization and/or invasion
of Salmonella Choleraesuis.
Salmonella is able to invade and survive
within macrophages that in turn serve as vehi-
cles for bacteria to spread systemically. To
determine the basis for our observation that
fewer numbers of CP327 were present in mes-
enteric lymph nodes in ligated ileal loop exper-
iments, we performed in vitro assays of
bacterial invasion and survival in PAM. The
results show that, compared to the WT, muta-
tions in crp resulted in a 10% reduction in inva-
siveness of CP327 (Fig. 3B). These results can
be compared with those from co-cultivation of
PAM with a non-invasive strain of E. coli
(K12) where only 4% of the viable bacteria
were recovered, representing a background
level of bacterial phagocytosis by PAM. In
comparing the bacterial survival rate within
PAM, it was noted that both Salmonella strains,
but not E. coli K12, were able to survive within
PAM. However, there was no signiﬁcant
Figure 1. Salmonella Choleraesuis Dcrp is attenuated in BALB/c mice. Survival of mice was recorded up
to 3 weeks after peroral (p.o.) or intraperitoneal (i.p.) administration of varying doses of Salmonella
Choleraesuis (WT) or the CP327 strain. Data are representative of two independent experiments (n =5i n
each group).
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the percent of viable Salmonella strains
decreased to approximately 25% (Fig. 3C).
3.4. Secretion of SPI-1 effector proteins SopB
and SipB was impaired in Dcrp
The SPI-1 encoded T3SS delivers a set of
effector proteins which facilitates bacterial entry
into intestinal epithelial cells [45]. To under-
stand whether a mutation in the crp gene
affected SPI-1 T3SS and contributed to the
impaired intestinal invasiveness of Salmonella
Choleraesuis, the secretory function of SPI-1
T3SS was investigated by ectopic expression
of the Myc-tagged recombinant effector
proteins SopB and SipB in WT and mutant
strains. It was observed that, under conditions
that induced SPI-1 T3SS, WT bacteria success-
fully expressed the recombinant protein SopB
and secreted it into the supernatant (Fig. 4A).
To investigate whether the presence of
SopB in culture supernatants was attributed to
spontaneous bacterial lysis, the leakage of
Figure 2. Salmonella Choleraesuis Dcrp is more resistant to low pH or bile salts. Bacteria grown to
stationary phase in LB broth were incubated for 1 h in M9 medium at pH 3.0 or 7.0 (A) or in saline, 15%
bile salts, or 1% sodium deoxycholate (B). Survival of bacteria before and after incubation was determined
on MacConkey agar plates. Percent survival was normalized to the initial inoculum. WT, wild type
Salmonella Choleraesuis; CP327 and CP359, crp gene mutants; Comp., CP327 complemented with pTCRP
plasmid; BS, bile salts; DOC, sodium deoxycholate. The results are from three independent experiments of
at least triplicate determinations. Error bars are SEM. *p < 0.05; ***p < 0.001; n.s.: no signiﬁcant
difference from each other (ANOVA).
Vet. Res. (2010) 41:05 Z.-W. Chen et al.
Page 8 of 14 (page number not for citation purpose)Figure 3. Salmonella Choleraesuis Dcrp was less invasive in porcine ligated ileal loops and in
macrophages. The degree of intestinal invasion by wild type Salmonella Choleraesuis (WT) and CP327 was
determined at 3 h after inoculation of the loops (A). To recover bacteria, portions of the ileal wall with Peyer
patches (PP) and associated mesenteric lymph nodes (LN) were harvested, homogenized, and plated onto
BG agar. The results are from at least triplicate determinations. For in vitro invasion (B) and intracellular
survival assays (C), porcine alveolar macrophages were co-cultured with WT and CP327 of Salmonella or
E. coli (K12) strains at an MOI of   20 for 2 h and intracellular survived bacteria were assessed. Relative
invasion was determined at 4 hpi while intracellular survival rates were at 8 and 16 hpi. The results are
representatives of three independent experiments of at least triplicate determinations. Error bars are SEM.
*p < 0.05 and ***p < 0.001 compared to WT; n.s.: no signiﬁcant difference from each other (ANOVA).
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examined by probing the same immunoblot
with a DnaK-speciﬁc antibody. The lack of a
DnaK signal in the bacterial culture supernatant
conﬁrmed that SopB was indeed secreted and
not released due to bacterial lysis. By contrast,
recombinant SopB was ectopically expressed
in CP327, however, secretion of this protein
was not detectable in the culture supernatant
(Fig. 4A). To exclude the possibility that the
altered function of SPI-1 T3SS was due to
genetic manipulations used during the construc-
tion of CP327, an isogenic phoQ gene mutant
PQ518 strain, constructed using a similar strat-
egy, was tested for SopB secretion. The results
showed that the secretory phenotype of PQ518
was comparable to that of the WT strain
(Fig. 4A) suggesting that the genomic manipu-
lation procedures used in this study did not
affect SPI-1 T3SS.
To further demonstrate that the impairment
of SPI-1 T3SS was a general effect and not
restricted to SopB, secretion of another effector
protein SipB was also assessed (Fig. 4B).
Recombinant SipB was secreted efﬁciently in
WT bacteria. However, there was no detectable
signal in the supernatant of CP327 cultures
even though a large amount of SipB was
expressed within the CP327 cells (Fig. 4B).
Furthermore, complementation of CP327 with
co-expressed recombinant CRP restored the
ability of the mutant to secrete SopB extracellu-
larly, while complementation with a control
plasmid remained non-secretory (Fig. 4C).
3.5. Caspase-1-dependent cytotoxicity in RAW
264.7 macrophage cells was reduced in Dcrp
Salmonella is known to activate caspase-1-
dependent cytotoxicity in macrophages by
Figure 4. Secretion of effector proteins SopB and SipB via SPI-1 T3SS was impaired in Dcrp. Wild
type (WT), CP327 or PQ518 strains transformed with pUC19 (v1), pUC19 encoding sopB-myc (SopB),
sipB-myc (SipB), p705 M (v2) or p705 M encoding crp-myc (CRP) were grown under conditions that
induced SPI-1 T3SS function. Bacterial culture supernatants (sup.) and pellets (bac.) were harvested,
normalized and subjected to Western blot analysis with an antibody to Myc-tag. The results of the
SopB secretion assay in WT, CP327 and PQ518 strains (A), SipB secretion assay in WT and CP327
(B) and SopB secretion assay in CP327 complemented with p705CRP (C). Immunoblots were also
probed with an anti-DnaK antibody as a loading control and to detect signals resulting from bacterial
lysis. The average intensity of secreted proteins was quantiﬁed and normalized to the intensity of DnaK
for WT, CP327 and PQ518 strains (A, lower panel).
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to the cell membrane [25, 38]. To determine
whether there was impaired secretion of SipB
by Dcrp affected macrophage cytotoxicity,
RAW 264.7 cells were co-cultured with Salmo-
nella at an MOI of   50 for 6 h in the presence
of the caspase-1-speciﬁc inhibitor Ac-YVAD-
CMK or DMSO and subjected to cytotoxicity
analysis using an LDH release assay. The
results showed that WT Salmonella Cholerae-
suis induced approximately 35% cytotoxicity
in RAW 264.7 cells and the addition of
Ac-YVAD-CMK signiﬁcantly reduced cytotox-
i c i t yt o2 3 %( Fig. 5). By contrast, cytotoxicity
caused by CP327 or CP359 strains was
only   14%, indicating that Dcrp mutants were
less cytotoxic to macrophages (Fig. 5). To fur-
ther conﬁrm that the reduction in cytotoxicity
was attributed to the mutation of the crp gene,
the effect of CRP complementation was inves-
tigated. It was noted that when complemented
with a plasmid expressing CRP, the CP327
strain regained the ability to induce cytotoxicity
in macrophages and the cytotoxicity was
reduced signiﬁcantly by a caspase-1 inhibitor
Ac-YVAD-CMK (p < 0.01) (Fig. 5).
4. DISCUSSION
The application of live Salmonella vaccines
as a preventive measure has been effective in
the control of swine salmonellosis [32]. By elic-
iting effective humoral and cellular immune
responses in the vaccinated animals, live
Salmonella Choleraesuis vaccines harboring a
mutation in crp have been shown to induce pro-
tectiveimmunityinmiceandpigs[8,20].Oneof
the characteristics of such mutants is the attenu-
ation in virulence due to unknown mecha-
nism(s). In this study, we showed that, at the
early stage of infection, the attenuation in Dcrp
was not attributed to increased susceptibility to
low pH or bile salts, but to a reduction in inva-
siveness associated with an impairment of the
secretory function of SPI-1 T3SS and lower
invasion rate and cytotoxicity to macrophages.
Thisstudyis the ﬁrst todemonstrate thata muta-
tioninthecrpgeneleadstoafunctionaldefectin
the SPI-1 T3SS and to delineate the role of CRP
in Salmonella Choleraesuis virulence.
Genes targeted for the development of
live Salmonella vaccines fall into two major
categories, metabolic and virulence-associated
Figure 5. Salmonella Choleraesuis induced caspase-1 dependent cytotoxicity in RAW 264.7 cells was
impaired in Dcrp mutants. Bacteria grown under conditions that induce SPI-1 T3SS were co-cultured at a
MOI of   50 with RAW 264.7 cells treated with 0.5% DMSO carrier (Vehicle) or with 50 lM caspase-1
inhibitor Ac-YVAD-CMK (Casp-1). Cell death was assessed at 6 hpi by measuring the release of lactate
dehydrogenase (LDH). WT, wild type Salmonella Choleraesuis; CP327 and CP359, crp gene mutants;
Comp., CP327 complemented with pTCRP plasmid. The results are from three independent experiments of
at least triplicate determinations. Error bars are SEM. **p < 0.01; ***p < 0.001; n.s.: no signiﬁcant
difference from each other (ANOVA).
Salmonella Choleraesuis Dcrp affects SPI-1 T3SS Vet. Res. (2010) 41:05
(page number not for citation purpose) Page 11 of 14genes, of which, the former were found to be
more immunogenic [23]. Nevertheless, not all
mutants deﬁcient in a metabolic-gene are atten-
uated or effective in inducing immunity. For
example, in contrast to the ﬁndings in Salmo-
nella Typhimurium [17], Nnalue et al. (1987)
reported that Salmonella Choleraesuis strains
with mutations in the aroA (aromatic biosynthe-
sis) or galE (UDP-glucose-4-epimerase) genes
were attenuated, but did not induce a protective
response in BALB/c mice [27]. Distinctively,
mutations in the crp gene of Salmonella enter-
ica serovars Typhimurium, Choleraesuis, or Ty-
phi lead to the attenuation of yielding strains
that may serve as effective vaccine candidates
in mice, pigs, horses or human beings [8, 20,
33, 35, 43]. However, it is not clear how crp
mutants display reduced virulence yet manage
to elicit a protective host immune response.
Using ligated ileal loops of pigs, we found
that intestinal invasion of Salmonella Cholerae-
suis Dcrp was signiﬁcantly impaired as com-
pared to WT. Nevertheless, there were still
approximately 10
6 CFU (per gram of tissue)
of Dcrp attached to or invaded into the ileum
wall, and 10
3 CFU (per gram of tissue) of Dcrp
were able to reach mesenteric lymph nodes,
suggesting that the ability of Dcrp to invade
intestinal tissues was not fully abolished and
that a pathway independent of SPI-1 T3SS
might have allowed Salmonella-infected phago-
cytes to gain access and spread to mesenteric
lymph nodes, where the immune response
occurs. This hypothesis is supported by
other investigations showing that Salmonella
Typhimurium deﬁcient in SPI-1 also gained
access to the spleen from the intestine [13]
and that CD18-expressing phagocytes are
responsible for the extra-intestinal dissemina-
tion of Salmonella [39]. Therefore, it is plausi-
ble that Salmonella Choleraesuis crp mutants
might also invade and subsequently induce
immune responses in the spleen and/or lymph
nodes via a similar pathway. Moreover, because
SPI-1 T3SS activity was impaired in Salmo-
nella Choleraesuis Dcrp, we speculate that the
immunogenicity of Salmonella Choleraesuis
does not rely on a functional SPI-1 T3SS. This
hypothesis is supported by a recent study that
demonstrated that protection against Salmonella
Typhimurium in pigs is independent of SPI-1
T3SS secreted proteins [3].
Survival within macrophages is an essential
feature of Salmonella pathogenesis in vivo
[12].Inthisstudy,wefoundthattheDcrpmutant
was less invasive for PAM as compared to WT,
but the survival rates were similar. Therefore, a
reduction inthe invasiveness of theDcrp mutant
probably accounts for the reduced number of
Dcrp cells observed in mesenteric lymph
nodes of ligated ileal loops. Other investigators
have demonstrated decreased colonization of
Peyer patches and spleens of mice infected by
Salmonella Choleraesuis strains having muta-
tions in the crp/cya genes. Moreover, adhesion/
invasion in CHO cells and bacterial transcytosis
in polarized Madin–Darby canine kidney cells
was signiﬁcantly reduced as compared to WT
[19]. Taken together, these ﬁndings strengthen
our results that suggest these phenotypes are
correlated to impaired SPI-1 T3SS function in
Salmonella Choleraesuis Dcrp.
However, CRP is pleiotropic and mutations
in the crp gene have been shown to alter diverse
characteristics of Salmonella including carbon
source utilization, synthesis of ﬂagella, reduced
growth rate, and attenuation in virulence [9,
43]. Due to the versatile role of CRP, we cannot
exclude the possibility that virulence determi-
nants other than SPI-1 T3SS may also be
affected in Salmonella Choleraesuis Dcrp.F o r
example, a recent report indicated that there is
a signiﬁcant decrease of SPI-2 gene expression
in the crp mutant of Salmonella Typhimurium
[41]. Also, our results show that a mutation in
the crp gene increased the resistance of Salmo-
nella Choleraesuis to low pH or bile salts, and
Dcrp was more resistant to gentamicin as com-
paring to the parental strain (data not shown).
These data led us to hypothesize that a mutation
in crp might have effects on the composition or
structure of the cell wall resulting in decreased
permeability to bile salts or gentamicin.
In conclusion, this study explored the
gastrointestinal factors that affect Salmonella
Choleraesuis Dcrp colonization/invasion and
provides evidence to delineate one of the atten-
uation mechanisms of Salmonella Choleraesuis
Dcrp that is widely approached as a candidate
of live Salmonella vaccine.
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